For rat pituitary cells, progesterone receptor (PR) protein localizes to gonadotropes and PR messenger RNA is induced by E 2 and rapidly but transiently down-regulated by progesterone. Here we quantitatively establish the down-regulatory effect of progesterone on PR protein and evaluate possible mechanisms. Nuclear PR-immunoreactivity (PR-IR) in gonadotropes, identified by dual immunofluorescence, was analyzed by quantitative confocal microscopy. Pituitary cells from female rats were cultured Ϯ 0.2 nM E 2 for 3 days. We confirmed the E 2 requirement for PR induction in gonadotropes and determined that the increase in PR-IR required about 24 h. After removal of E 2 , PR-IR decreases were not found until 24 -36 h. Addition of progesterone (40 nM) to E 2 -treated cells led to a dramatic loss in PR-IR by 9 h (26% of control); by 24 h, PR-IR was barely detectable. Reappearance of nuclear PR-IR required progesterone removal (8-fold increase by 12 h after progesterone removal) and protein synthesis (cycloheximide inhibited the reappearance of PR-IR). Although progesterone decreased PR-IR whether or not E 2 was present concurrent with progesterone, the recovery of PR-IR required E 2 . RU486 completely blocked progesterone-induced PR down-regulation. Because the sustained progesterone-induced loss of PR protein did not correlate with previously reported temporal changes in PR messenger RNA levels, we examined a role for protein degradation. When cells were coincubated with progesterone and the proteasome inhibitor, MG132 (1 M), the expected decrease in PR protein was abrogated. In summary, progesterone leads to a rapid and extensive reduction in nuclear PR protein in gonadotropes. The progesterone-dependent downregulation of PR occurs, at least in part, by a proteasome-mediated pathway. Recovery of PR protein requires removal of progesterone, the presence of E 2 , and protein synthesis. These dynamic changes in nuclear PR levels coincide with the temporal extent of the preovulatory LH surge in rats and could provide a basis for progesterone's biphasic action on LH secretion. (Endocrinology 141: [3422][3423][3424][3425][3426][3427][3428][3429] 2000) 
gesterone decreased PR-IR whether or not E 2 was present concurrent with progesterone, the recovery of PR-IR required E 2 . RU486 completely blocked progesterone-induced PR down-regulation. Because the sustained progesterone-induced loss of PR protein did not correlate with previously reported temporal changes in PR messenger RNA levels, we examined a role for protein degradation. When cells were coincubated with progesterone and the proteasome inhibitor, MG132 (1 M), the expected decrease in PR protein was abrogated. In summary, progesterone leads to a rapid and extensive reduction in nuclear PR protein in gonadotropes. The progesterone-dependent downregulation of PR occurs, at least in part, by a proteasome-mediated pathway. Recovery of PR protein requires removal of progesterone, the presence of E 2 , and protein synthesis. These dynamic changes in nuclear PR levels coincide with the temporal extent of the preovulatory LH surge in rats and could provide a basis for progesterone's biphasic action on LH secretion. R EGULATION of the number of available progesterone receptors (PRs) is subject to multiple influences with cell-and time-specific constraints. For PRs in the anterior pituitary gland, estrogen is an established positive regulator in female rats and monkeys. In these species, estrogen upregulation of pituitary PR messenger RNA (mRNA) has been shown by in situ hybridization, Northern blot, and RT-PCR (1-3). For pituitary PR protein, estrogen-regulated increases have been demonstrated by functional binding assays, immunoblot, and immunocytochemistry (2, 4 -9) . This positive regulatory action of estrogen on the PR is consistent with many other tissues and cell lines except for the ovary where PR regulation primarily is steroid independent (10) .
Pituitary PR is subject to down-regulation by progesterone, although the mechanisms involved in this regulation have not been resolved. For monkey pituitary cells, Bethea and colleagues report that progesterone can reduce pituitary PR mRNA levels (1); the down-regulatory effect of progesterone on pituitary PR protein was found to be a complex response depending on time course (9, 11) . For cultured rat pituitary cells, we reported a rapid down-regulation of PR mRNA occurring within 3 h of exposure to progesterone with recovery by 12 h; there was suggestive evidence for a decrease in PR protein but with no recovery within this time frame (2) . In an in vivo study, Szabo et al. (3) found no effect on pituitary PR mRNA levels at 17 h after progesterone treatment, the only time point examined.
Localization of the PR within the pituitary gland is restricted to gonadotropes in rats and monkeys (2, 9, 12, 13) , and, therefore, mechanisms for regulating PR levels in females might be expected to reflect the varying temporal requirements of a reproductive cycle. The dynamic regulatory changes demanded during the preovulatory period are particularly impressive. In the rat, for example, the LH surge has a duration of about 10 h; with a slight delay in onset, serum progesterone mirrors the LH profile and has a duration of about 12 h (14) . During this period, progesterone has a biphasic effect on LH secretion, starting with a severalfold augmentation of the LH release action of GnRH and ending with a suppression of the efficacy of GnRH (15) (16) (17) (18) (19) (20) . One potential mechanism subserving the demands of the system during this period could relate to alterations in the levels of available PR protein in gonadotropes.
An essential consideration is that PR mRNA and protein may be regulated differentially within this physiological context in gonadotropes. For example, in other cell types there is evidence that the stability of PR protein is profoundly affected by the presence of progesterone, and this effect can be independent of changes in PR mRNA (21) . There are similar reports for liganddependent degradation of the estrogen receptor (22, 23) and the glucocorticoid receptor (24, 25) .
These reports and our previous study of PR expression in gonadotropes (2) led us to hypothesize that, within a time course consistent with its physiological actions during the preovulatory LH surge, progesterone results in a down-regulation of nuclear PR protein independent of its effect on PR mRNA. The aims, therefore, of the present study were to quantitatively establish the down-regulatory effect of progesterone on nuclear PR protein under conditions known to cause a transient down-regulation of PR mRNA in cultured gonadotropes and to evaluate mechanisms involved in this pituitary action of progesterone. To assess nuclear PR we adapted quantitative confocal microscopy techniques for the analysis of nuclear PR-immunoreactivity (PR-IR) in individual gonadotropes, identified by dual immunofluorescence. Part of this study has been presented in preliminary form (26) .
Materials and Methods Materials
Adult, female Sprague Dawley rats (Simonsen Laboratories, Inc., Gilroy, CA) were maintained in controlled light conditions (14-h light, 10-h dark). Media and sera for cell culture were as described previously (18) . Progesterone was obtained from Calbiochem (San Diego, CA); 17␤-estradiol (2) and cycloheximide were from Sigma (St. Louis, MO). RU486 was a gift from Roussel-UCLAF (Romainville, France). Steroids were prepared as stock solutions in ethanol. The proteasome inhibitor, MG132, was obtained from Calbiochem and stored frozen as stock solution in dimethyl sulfoxide. For experiments final concentrations did not exceed 0.01% for ethanol and 0.01% for dimethyl sulfoxide.
For immunofluorescence, normal goat serum (NGS) was from Vector Laboratories, Inc. (Burlingame, CA), tetramethyl rhodamine isothiocyanate (TRITC)-conjugated goat antimouse IgG was from Sigma, fluorescein isothiocyanate (FITC)-labeled goat antirabbit IgG was from Sigma, TOTO-3 iodide was from Molecular Probes, Inc. (Eugene, OR), and Vectashield mounting medium was from Vector Laboratories, Inc. Mouse monoclonal antibody 518B7 to bovine LH␤ (27) was provided by Jan Roser (University California, Davis). The polyclonal antibody used for analysis of PR was as described previously (2) ; it reacts with both the A and B forms of murine PR (28) .
Pituitary cell culture and experimental protocols
Protocols employed in these experiments were reviewed and approved by the University of California Davis Animal Use and Care Administrative Advisory Committee. Rats were ovariectomized under ether anesthesia and maintained for two weeks before use. Pituitary glands were removed from rats following CO 2 narcosis and decapitation. Anterior pituitary tissue was enzymatically dispersed and prepared for cell culture as described (18) . Cells were plated at 5 ϫ 10 4 on Matrigel-coated 12-mm glass coverslips placed in 22-mm multiwell plates. Wells were flooded with minimum essential medium containing d-valine and supplemented with 200 m kanamycin sulfate (MEM-K), 10% FBS that had been charcoal treated to remove endogenous steroids [ctFBS (29) ], and plus or minus 0.2 nm E 2 . Residual steroid concentrations in the ctFBS were 3 pm for progesterone and less than 1 pm for E 2 as determined by RIA. Cells were maintained in a humidified atmosphere (37 C) of 5% CO 2 in air; on day 2, media were replenished (day of plating ϭ day 1).
On day 4, the cells were changed to serum-free MEM-K containing 1 mg BSA/ml (MEM/BSA) with or without experimental treatments. In experiments to determine the effect of E 2 on the appearance of the PR in the nucleus, cells that had been incubating without estrogen were exposed to 0.2 nm E 2 for varying periods from 0 -36 h. For experiments to determine the effect of progesterone on nuclear PR-IR, cells that had been incubating in E 2 -containing medium were changed into MEM/ BSA Ϯ 40 nm progesterone, Ϯ RU486 (40 or 200 nm), Ϯ 0.2 nm E 2 , and Ϯ MG132 (1 or 10 m) for varying periods for up to 36 h. To assess nuclear PR recovery, for some wells in these groups the media were changed after 12 h, the cells rinsed 2ϫ in MEM/BSA, and incubation was continued in the absence of progesterone Ϯ E 2 and Ϯ 5 m cycloheximide for 12 or 24 h. For all treatment groups, termination was accomplished by rinsing the cells in PBS at room temperature followed by fixation with precooled methanol:acetone (1:1) for 7 min at Ϫ20 C; fixed cells were stored in PBS at 4 C until subjected to immunofluorescence staining.
Immunocytochemistry
Immunofluorescence staining was carried out at room temperature by successive incubation of the coverslips in the following solutions: 1) 5% NGS, 1 h; 2) anti-LH (1:500) and anti-PR (1:750), 2 h; 3) PBS-0.1% BSA-0.1% tween 20 (PBSA) washes; 4) 5% NGS, 30 min; 5) TRITC conjugated goat antimouse IgG (1:160), 1 h; 6) PBSA washes; 7) FITC labeled goat antirabbit IgG (1:160) and 2.4 nm TOTO-3 nuclear DNA stain, 1 h; 8) PBSA washes; 9) distilled water wash and mount using Vectashield mounting medium for fluorescence. As controls, either or both of the primary antibodies were omitted for some coverslip incubations. All antibodies were diluted in 5% NGS.
Confocal microscopy
Microscopy data were obtained with a Carl Zeiss LSM 510 laser scanning confocal microscope (Carl Zeiss, Inc., Thornwood, NY) using a 40ϫ/1.3 N.A. lens. Fluorescence data were collected in three separate channels: channel 1 was set to collect fluorescence of the nuclear stain TOTO-3 (excitation: 633 nm; emission: 650 nm Long Pass filter); channel 2 collected FITC fluorescence, PR-IR, (excitation: 488 nm; emission: 505-530 nm Band Pass filter); channel 3 collected TRITC fluorescence, LH, (excitation: 543 nm; emission: 560 -615 nm Band Pass filter). For each channel and for all collections, the pinhole was set to 250 m, giving an optical slice of approximately 3 m. Additionally, a transmitted light image was obtained in channel 4. Overlapping optical slices (22-28; step size approximately 1 m) were obtained through the entire cell. Each slice was 1024 ϫ 1024 pixels and had a pixel depth of 8 bits. Subsequently, from the data set of each cell, a single optical slice was selected for analysis as described below.
Data analysis
As we reported previously for the ovariectomized rat anterior pituitary cells in primary culture, LH immunoreactive cells constitute 7-8% of the cell population and PR-IR and LH colocalize in 98 -100% of these cells (26) . For the present study, only cells that stained positively for LH were selected for analysis. The optical slices for each gonadotrope were examined and the slice containing the maximum nuclear diameter was used for analysis of PR-IR. The selected images were exported in TIFF format and analyzed using ImageJ (available from the NIH: http:// rsb.info.nih.gov/ij/applet/). Each exported TIFF file was converted to an 8-bit RGB stack. Using the RGB stack the net mean nuclear PR-IR was determined as the gray-scale intensity in the G (Green; channel 2) channel minus the corresponding background value (relative intensity units).
Data are presented as mean Ϯ sem. Three to 17 cells were analyzed on each coverslip and averaged; therefore, n refers to the number of coverslips examined from separate experiments and reflects a minimum of three separate cell dispersions per experimental group. All statistical analyses were done using SigmaStat (SPSS, Inc., Chicago, IL). For multiple comparisons, differences between groups were determined by ANOVA and the Student's-Neuman-Keuls method; where differences are indicated as being significant, P Ͻ 0.05. For regression analysis, the slope of the regression line was tested for significance.
In immunocytochemical studies, there are several potential sources of variation in fluorescence intensity in addition to those attributable to treatment effects. For this study, the sources of noise in the PR-IR signal include inherent biological variation in the cell to cell expression of PR. Additionally, there is the experimentally introduced variability inherent in the fixation and immunostaining procedures, even though these methods were standardized and unchanged throughout these experiments. To aid in assessment of the variability introduced by these factors, independent of treatment effects, the E 2 continued-12 h experimental group was included in each experiment. For this group, we assessed the variation between cells on the same coverslip as a measure of biological variability, and we examined the results between these independently immunostained coverslips for the combined effects of immunostaining and fixation. The objective was to estimate the magnitude of the random variation and, further, to assess the presence of systematic errors. We found that biological variation and variation in the fixation and immunostaining procedures each contribute significantly to the observed variation in PR-IR; however, these variations were shown statistically to be random and did not exhibit systematic variation over the course of these experiments.
Results

E 2 addition: time course for increase in PR-IR
We first sought to establish whether or not nuclear PR-IR was detectable in gonadotropes cultured in the absence of E 2 . In our previous study using conventional epifluorescence microscopy to visualize PR-IR in cultured gonadotropes, nuclear PR was undetectable in anterior pituitary cells cultured in the absence of E 2 but showed strong immunoreactivity in cells cultured for 3 days in the presence of E 2 (2) . In the present study using confocal microscopy, very low level immunoreactivity for nuclear PR was detected above background in some but not all gonadotropes cultured for 3 days without added E 2 . Following the addition of E 2 to serum-free medium, nuclear PR-IR significantly increased over the next 36 h ( Fig. 1 ; regression analysis, P Ͻ 0.001). For all subsequent studies described below, pituitary cells were cultured in the presence of 0.2 nm E 2 for 3 days before the experimental manipulations were initiated. Shown in Fig. 2 (A and B) are examples of immunofluorescence staining of pituitary cells on day 4 of culture in E 2 ; gonadotropes, identified by cytoplasmic LH immunoreactivity (red), show nuclear PR immunoreactivity (green).
E 2 removal: effect on PR-IR
To analyze the requirement for the continued presence of E 2 on PR-IR in cultured gonadotropes, we examined nuclear PR-IR following removal of E 2 from the culture medium on day 4. As shown in Table 1 , for the first 12 h after E 2 removal there was no significant difference in PR-IR compared with that found in gonadotropes that continued to incubate in E 2 -containing medium. However, over 36 h there was a significant decrease in nuclear PR-IR for the E 2 -removed cells (regression analysis, P Ͻ 0.01).
PR down-regulation and recovery
Our previous studies provided suggestive evidence for a decrease in nuclear PR-IR in gonadotropes following progesterone exposure; however, the methods used allowed only limited quantitative analysis (2) . In the present study, using confocal microscopy and tools that provide extensive and consistent control of data acquisition, we examined the time course of this acute progesterone effect. As shown in Fig.  3 for gonadotropes cultured for 3 days in E 2 , a significant decrease in PR-IR was detected by 9 h after the addition of 40 nm progesterone to serum-free medium (26 Ϯ 8% of control). By 24 h of exposure to progesterone, there is a near disappearance of nuclear PR-IR in gonadotropes (3 Ϯ 0.4% of control) (Fig. 2C) . As our earlier studies had shown that under these conditions PR-mRNA in gonadotropes decreased following progesterone exposure but returned to control levels by 12 h even in the continued presence of progesterone (2), we next asked if removal of progesterone would allow nuclear PR protein to recover. For these experiments, cells exposed to progesterone and E 2 for 12 h were rinsed and incubation was continued in the presence of E 2 alone for 12 or 24 h. As shown in Fig. 2D and Fig. 3 , removal of the progesterone resulted in a significant recovery of nuclear PR-IR. By 12 h, there is an 8-fold increase over that which is found if progesterone had remained in the incubation medium (Fig. 3 and Table 2 ; compare prog 24 h vs. prog 12 h/prog removed 12 h groups). The PR-IR showed a tendency to increase with time after progesterone removal but the increase was not significantly greater at 24 h than that found 12 h after progesterone removal (Fig. 3) .
In these progesterone removal studies, E 2 was present throughout. Therefore, we next asked whether the decrease in nuclear PR is secondary to interference by progesterone in the action of E 2 to promote PR production and whether the presence of E 2 is required for PR recovery after progesterone removal. As shown in Table 2 , if E 2 is removed concurrent with progesterone addition (E 2 discontinued ϩ prog group), the decrease in nuclear PR-IR in gonadotropes after 12 h is not significantly different than that found when E 2 is continued. This suggests that the acute down-regulation of PR protein by progesterone in gonadotropes does not involve interference with the E 2 receptor under these conditions. However, during the subsequent 12 when progesterone is removed from the incubation medium, the recovery of nuclear PR is abolished unless E 2 is present ( Table 2) . To further define the conditions necessary for nuclear PR recovery after progesterone removal, we examined the effect of the translation inhibitor, cycloheximide. If the inhibitor is added concurrent with the removal of progesterone, the recovery of nuclear PR-IR in the subsequent 12 h is prevented (Table 2) . Thus, under these conditions, once gonadotropes are exposed to progesterone and PR protein is down regulated, the reappearance of nuclear PR-IR requires the absence of progesterone, the presence of E 2 , and protein synthesis.
Interference with progesterone's action
In the next series we asked whether interfering with progesterone binding to its nuclear receptor could block the progesterone-induced down-regulation of the PR. When go- nadotropes were incubated in equimolar concentrations (40 nm) of RU486 and progesterone, the decrease in nuclear PR-IR usually seen at 12 h of progesterone exposure was prevented by RU486, although there was considerable variation on a cell to cell basis as is reflected by the large sem (Fig.  4) . Increasing the concentration of RU486 5-fold resulted in a complete block of the progesterone-induced PR downregulation; RU486 by itself over 12 h had no significant effect on nuclear PR-IR in gonadotropes (Fig. 4) .
Because of the reports showing that ligand-dependent down-regulation of either the PR or the estrogen receptor in tumor cells or in transfected cells occurs by a proteasomemediated pathway (21, 22) , we asked whether the PR downregulation we observed in primary cultured gonadotropes could be abrogated by the proteasome inhibitor, MG132. When progesterone and 1 m MG132 were added simultaneously and incubation continued for 12 h, nuclear PR-IR in gonadotropes was about 50% of control cells incubated without progesterone or the proteasome inhibitor and significantly greater than cells incubated in progesterone alone (Fig.  5) . Preincubating gonadotropes in 1 m MG132 for 3 h before the addition of progesterone resulted in PR-IR that was about 70% of the zero-progesterone control, but the pretreatment regimen did not significantly improve the inhibitor's effectiveness compared with simultaneous addition (Fig. 5) . Representative confocal microscopy images are shown in Fig. 2  (E-F) . MG132 (1 m) by itself for 12 h had no significant effect on nuclear PR-IR (Fig. 5) . In an attempt to more completely reverse the progesterone-induced decrease in nuclear PR-IR, we increased the concentration of the proteasome inhibitor 10-fold. However, when gonadotropes were exposed to 10 m MG132 for 12 h, the pattern of PR-IR was different than found for any other treatment groups in that PR-IR exhibited one or two focal points or "hot spots" of saturated fluorescence in the nucleus instead of the usual relatively homogeneous nuclear distribution. This occurred whether or not progesterone was present. Because this unusual spatial phenomenon was exclusively found with the higher concentration of MG132 and also presented problems with fluorescence intensity analysis, we have not included the data in the final comparisons.
Discussion
Steroid receptor availability is a highly regulated and complex process with cell-and context-specific adaptations. In this work we focused on changes in nuclear PR protein levels in female pituitary gonadotropes in culture. We specifically asked whether progesterone-induced PR protein changes occurred in a time course consistent with the dynamic events of the preovulatory LH surge. As an adjunct, we asked whether changes in PR protein levels could be temporally aligned to the progesterone-induced changes in PR mRNA that we previously reported for cultured gonadotropes (2) .
In the absence of E 2 , nuclear PR is barely detectable with confocal microscopy, and this dependence of PR protein on estrogen stimulation is consistent with previous reports for pituitary cells (2, 4 -9) . It is possible that the low level of PR we observed represents estrogen-independent activity involving, e.g. serum growth factors, but an alternative explanation to account for the presence of minimal PR could be residual estrogen in the charcoal-treated serum (final E 2 concentration estimated in the femtomolar range). It is clear, however, that the addition of E 2 in the picomolar range led within 24 h to a clear increase in nuclear PR in gonadotropes that had been cultured without added E 2 for several days. This increase in PR protein is in line with the E 2 -induced increase in PR mRNA in rat gonadotropes under similar culture conditions (2) or in vivo (3) .
In contrast to estrogen's positive action on gonadotrope PR, progesterone exhibited a clear down-regulation of PR protein within 9 h, reaching barely detectable levels by 24 h of exposure. Functionally, this decrease in PR could account for the observed abrogation of progesterone's acute positive action on GnRH-stimulated LH secretion that occurs on the downslope of the preovulatory LH surge (16 -20) and may be involved in the extinction of the surge (15) . In the rat, the LH surge occurs over 8 -10 h and is accompanied by a progesterone surge (15) , which initially serves to substantially augment the LH release action of GnRH (16 -18, 30, 31) . The striking down-regulation of nuclear PRs within 9 h of exposure to progesterone could account for the observed loss of the positive action of progesterone on GnRH-stimulated LH secretion and could affect the duration of the preovulatory   FIG. 3 . Time course for progesterone-induced down-regulation of PR: Dispersed anterior pituitary cells from ovariectomized rats were cultured in 0.2 nM E 2 for 3 days. On day 4, the cells were rinsed and incubated in MEM/BSA containing 0.2 nM E 2 plus 40 nM progesterone (Prog) for the times indicated; controls were incubated in E 2 only (3, 12, 24, or 36 h). In some groups, after 12 h of exposure to prog, the cells were rinsed 2ϫ and incubation was continued in E 2 -medium in the absence of prog for either 12 or 24 h (Removed). Cells were fixed and subjected to dual immunofluorescence staining for LH and PR as described for Fig. 1 . Data are presented as percent of control; no significant differences were found among the E 2 -only control groups. For the prog-treated groups, the first significant decrease in PR-IR is at 9 h with continual decline thereafter; by 12 h after prog removal, PR-IR is significantly increased (P Ͻ 0.05). Each bar represents the mean Ϯ SEM from 3-7 separate experiments; multiple cells were analyzed/coverslip with a range of 18 -68 cells/treatment group. As control for cycloheximide, cells were exposed to E 2 for the initial 12 h and to E 2 and cycloheximide for the subsequent 12 h; nuclear PR-IR intensity was 96 Ϯ 13, which was not significantly different than the E 2 /E 2 control.
N refers to the number of coverslips from separate experiments that were analyzed. Multiple cells were analyzed/coverslip with a range of 14 -68 total cells/group. LH surge. Indeed, it has been shown in cyclic rats in vivo that PRs fall from a high on proestrus to low levels on estrus (6, 32) . In the current study we narrow the time frame to show that the decrease in gonadotrope PR can occur within the temporal extent of the LH surge, and we provide support for the hypothesis that the loss of gonadotrope responsiveness to progesterone contributes to the termination of the preovulatory surge.
Mechanistically, the progesterone-induced sustained decrease in PR protein cannot be accounted for completely by changes in PR mRNA levels. As we reported for pituitary cells cultured under similar conditions in the presence of estrogen, progesterone causes a rapid but transient downregulation of PR mRNA. Steady-state PR mRNA levels decreased by 3 h of exposure to progesterone but had recovered by 12 h even in the continual presence of progesterone (2) . For PR protein in contrast, the decline is sustained for the duration of progesterone exposure; nuclear PR is barely detectable by 24 h (Fig. 3) . To recover nuclear PR protein, three conditions were required: removal of progesterone, the presence of estrogen, and ongoing translation. In the aggregate, this suggested that progesterone was directly affecting the stability of PR protein in gonadotropes.
Autologous down-regulation is common for steroid receptors. In T47D human breast cancer cells, for example, the half-life of PR protein is reported to be 21 h in control cells and only 6 h in the presence of a progesterone analog (33) . Recent reports suggest that, at least in part, ligand-induced decrease in receptors is due to degradation through a ubiquitin-proteasome pathway. In this pathway, which is present in the cytoplasm and nucleus of eukaryotic cells, substrates are degraded by a large multisubunit ATP-dependent protease complex, the proteasome (34 -36) . In most cases, the substrate is targeted for degradation by the attachment of ubiquitin moieties, and there is evidence for ubiquitination of the PR (21) as well as the estrogen and glucocorticoid receptors (22, 25) . We show in gonadotropes that, in the presence of the proteasome inhibitor MG132, the expected progesterone-dependent decrease in nuclear PR is partially prevented. This is consistent with a ligand-modulated destruction of the PR through the proteasome pathway. That the degradation of the PR was not completely inhibited could be related to the mode of action of MG132. This peptide aldehyde is a reversible, transition state analog, and at the concentration used in this study it may be less effective than the activated PR in competition for proteasome binding.
The exact mechanisms by which ligand binding promotes receptor degradation through the ubiquitin-proteasome pathway are not clear, but various strategies could be invoked depending on the cell context. For example, liganddependent dissociation of the steroid receptor from the hsp-90 chaperone system can destabilize the receptor, making it more accessible to the ubiquitin-proteasome system (reviewed in Ref. 37 ), and recent evidence shows that phosphorylation of PR activated by the progesterone analog R5020 can mark the receptor for destruction by the proteasome pathway (21) . In this latter study, a unique serine residue in the human PR was reported to be responsible for targeting the receptor for degradation in T47D breast cancer cell lines. Interestingly, although both progesterone and RU486 have been shown to increase phosphorylation of this serine in the human PR, the antiprogestin reduces PR protein levels only slightly and transiently or not at all in T47D cells (38, 39) , whereas in another human breast cancer cell line, MCF-7, RU486 is nearly as effective as progesterone in reducing PR levels (39) . Clearly, protein degradation must have multiple control points depending on cell context and could involve, for example, the conformational modifications in the substrate for targeting, specificity in the components of the ubiquitination enzymes, and regulation of pro -FIG. 4 . Blockade of progesterone-induced PR down-regulation by RU486: Pituitary cells were cultured for 3 days in E 2 as described in Fig. 3 . On day 4, the cells were rinsed and incubated in MEM/BSA containing 0.2 nM E 2 Ϯ RU486 or E 2 with 40 nM prog Ϯ RU486. After 12 h, the cells were fixed and subjected to dual immunofluorescence staining for LH and PR as described for Fig. 1 . Each bar represents the mean Ϯ SEM from 3-9 separate experiments; multiple cells were analyzed/coverslip with a range of 21-68 cells/treatment group. Bars not sharing the same letter are significantly different from each other (P Ͻ 0.05).
FIG. 5.
Blockade of progesterone-induced PR down-regulation by a proteasome inhibitor: Pituitary cells were cultured for 3 days in E 2 as described in Fig. 3 . On day 4, the cells were rinsed and incubated in MEM/BSA containing 0.2 nM E 2 Ϯ 1 nM MG132 or E 2 with 40 nM prog Ϯ MG132. The proteasome inhibitor was added either simultaneous with prog ("ϩ") or 3 h before prog addition ("pretreat"). After 12 h, the cells were fixed and subjected to dual immunofluorescence staining for LH and PR as described for Fig. 1 . Each bar represents the mean Ϯ SEM from 3-9 separate experiments; multiple cells were analyzed/coverslip with a range of 20 -68 cells/treatment group. Bars not sharing the same letter are significantly different from each other (P Ͻ 0.05).
teasome activation (22, 34 -36) . For degradation of nuclear hormone receptors or other transcription factors, the kinetics of DNA-receptor binding and the composition of the multicomponent transcription complex also could contribute to the cell or context variability in the timing and extent of receptor loss through the proteasome pathway (22, 40) .
In our studies, not only was RU486 by itself without effect on PR down-regulation, the PR antagonist was able to completely block the progesterone-dependent loss of nuclear PR in rat gonadotropes. This finding is consistent with an in vivo study of rat uterus in which the down-regulation of PR protein and mRNA by progesterone was prevented by simultaneous administration of RU486 (41) . Whether the action of the antagonist as a blocker of progesterone-dependent PR down-regulation in these studies compared with the action of RU486 on PR degradation in breast cancer cell lines (38, 39) is due to species differences in PR, receptor and coregulator levels, or primary tissue vs. cell lines is not known.
In summary, we show that progesterone leads to a clear down-regulation of nuclear PR protein in gonadotropes within 9 h of exposure. The loss of PR protein is due, at least in part, to degradation through the proteasome pathway; the appearance of new PR protein requires removal of progesterone and ongoing translation in the presence of E 2 . The time course for this progesterone-induced decrease in PR protein in gonadotropes coincides with the temporal extent of the preovulatory LH surge and accompanying progesterone increase in rats. We suggest that the progesterone surge, which initially serves to substantially augment the LH release action of GnRH, leads to loss of PR protein and consequently contributes to the termination of the LH surge.
